Recent Research from University of Texas, U.S., Reveals Insights into Molecular Imaging, DNA Ligase Activity, and Uric Acid Nephrolithiasis

Strategic Insights -

Research from the University of Texas, U.S., has been shedding light on various aspects of molecular imaging, DNA ligase activity, and uric acid nephrolithiasis. The studies have shown promising results in the fields of cancer research, embryonic development, and diabetes management.

Key Takeaways:

  • Recent research from the University of Texas, U.S., has chronicled the molecular imaging of epidermal growth factor receptor (EGFR) kinase activity in tumors using I-124-labeled small molecular tracer and positron emission tomography (PET).
  • The study found that PET imaging with EGFR kinase-specific radiolabeled tracers could provide a means for noninvasive and repetitive imaging of heterogeneity of EGFR expression and signaling activity in tumors in individual patients before and during therapy with EGFR signaling inhibitors.
  • Targeted inactivation of DNA ligase III in mice resulted in early embryonic lethality, indicating that DNA ligase III is involved in essential DNA repair activities required for early embryonic development.
  • Patients with type 2 diabetes who are not stone formers have lower 24-hour urine pH than normal volunteers, which is a main risk factor for uric acid nephrolithiasis.
  • Higher body mass and increased acid intake can contribute to but cannot entirely account for the lower urine PH in patients with type 2 diabetes.
  • Researchers suggest that PET imaging with morpholino-[I-124]-IPQA could allow for identification of tumors with high EGFR kinase signaling activity, including brain tumors expressing EGFRvIII mutants and nonsmall-cell lung cancer expressing gain-of-function EGFR kinase mutants.
  • Additional [I-124]-IPQA derivatives with improved water solubility may be required to optimize the pharmacokinetics of the molecular imaging agents.

Statistics:

  • Studies were conducted on subcutaneous tumor xenografts in immunocompromised rats and mice.
  • Mice homozygous for LIG3 disruption showed early embryonic lethality.
  • Urine pH inversely correlated with both body weight and 24-hour urine sulfate in all groups.
  • Patients with type 2 diabetes and uric acid stone formers had lower 24-hour urine pH than normal volunteers.
  • For a given urine sulfate, patients with type 2 diabetes tended to have a higher urine net acid excretion than normal volunteers.

Sources:

  • Pal, A., et al. (2006). Molecular imaging of EGFR kinase activity in tumors with I-124-labeled small molecular tracer and positron emission tomography. Molecular Imaging and Biology, 8(5), 262-277.
  • Pueblao-Sorio, N., et al. (2006). Early embryonic lethality due to targeted inactivation of DNA ligase III. Molecular and Cellular Biology, 26(10), 3935-3941.
  • Cameron, M.A., et al. (2006). Urine composition in type 2 diabetes: Predisposition to uric acid nephrolithiasis. Journal of the American Society of Nephrology, 17(5), 1422-1428.